Pfizer Inc has acquired Vicuron Pharmaceuticals Inc, a biopharmaceutical company focused on discovering, developing, manufacturing and commercializing vital medicine for seriously ill patients.

"This transaction builds on Pfizer's extensive experience in anti-infectives and demonstrates our commitment to strengthen and broaden our pharmaceutical business through strategic product acquisitions." — Hank McKinnell, chairman and chief executive officer of Pfizer, June 16, 2005

You will automatically be redirected to the Pfizer Corporate Web Site in 15 seconds.